Simone Lasagni

Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation

G. Giannelli, M. Martínez-Chantar, F. Ravaioli, 2022, Frontiers in Oncology.

Prognostic significance of hypoxic and metabolic gene profiling in hepatocellular carcinoma

G. Giannelli, L. Fabris, M. Martínez-Chantar, 2021 .

Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma

G. Giannelli, M. Martínez-Chantar, F. Dituri, 2022, Oncology letters.

Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19

R. Bruno, C. Celsa, T. Trenti, 2021, Blood Advances.

Dynamic Angiopoietin-2 Serum Level as Endothelial Damage Marker and Potential Therapeutic Target

D. Romagnoli, E. Villa, R. Critelli, 2022, The American Journal of Pathology.

Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids

G. Giannelli, L. Fabris, M. Cadamuro, 2023, Biomedicines.